ENROTAS

Each ml contains:
Enrofloxacin. 100 mg
Excipients. q.s.

Treatment of severe respiratory infections (CRD, CCRD).
Control of complicated enteric diseases (Colibacillosis, Salmonellosis).
Effective against infections caused by Mycoplasma species.
Management of systemic bacterial infections in poultry and livestock.
Highly effective against a wide range of antibiotic-resistant strains.

Enrofloxacin, a third-generation fluoroquinolone, acts by inhibiting essential bacterial enzymes known as DNA gyrase (Topoisomerase II) and Topoisomerase IV. These enzymes are crucial for supercoiling, replication, and repair of bacterial DNA. By blocking their action, Enrofloxacin prevents the bacteria from synthesizing or maintaining their genetic material, leading to rapid cell death. This potent, concentration-dependent action results in a broad-spectrum bactericidal effect against both Gram-positive and Gram-negative pathogens.

Broad-spectrum activity with rapid bactericidal action.
Achieves high therapeutic concentrations at the site of infection.
Excellent oral bioavailability for reliable systemic treatment.
Treats both Gram-positive and Gram-negative bacterial pathogens.
Convenient liquid formulation for easy administration via drinking water.

For oral administration
General Dosage: 10 mg Enrofloxacin per kg body weight daily.
Poultry: 0.5 mL of ENROTAS per 1 litre of drinking water.
Duration: Administer continuously for 3 to 5 days, or as directed by the attending veterinarian.
Note: Ensure medicated water is the only source of drinking water during treatment.

15 ml, 50 ml, 100 ml, 250 ml, 500 ml and 1000 ml HDPE Bottle

Oral Liquid